In vitro effect of adenosine agonist GR79236 on the insulin sensitivity of glucose utilisation in rat soleus and human rectus abdominus muscle  by Webster, Judith M. et al.
ELSEVIER Biochirnica et Biophysica Acta 1316 (1996) 109-113 
iii 
BB 
Bioch~Pic~a et Biophysica A~ta 
In vitro effect of adenosine agonist GR79236 on the insulin sensitivity of 
glucose utilisation in rat soleus and human rectus abdominus muscle 
Judith M. Webster, Lesley Heseltine, Roy Taylor * 
Department of Medicine, The Medical School, University of Newcastle upon Tyne, Framlington Place, Newcastle upon Tyne. NE2 4HH, UK 
Received 16 October 1995; accepted 2 February 1996 
Abstract 
The dose-response effects of a new adenosine agonist, GR79236, were examined in isolated rat soleus muscle strips and human rectus 
abdominus muscle strips. Effects on the insulin sensitivity of carbohydrate metabolism were examined, in particular upon insulin 
stimulated glycogen synthesis and glycolytic flux. In the presence of adenosine deaminase (ADA), GR79236 increased insulin sensitivity 
of pyruvate release from rat soleus muscle strips by 24% from 82.5 + 10.0 to 102.5 ___ 10.0 (P < 0.01), by 27% to 105.0 _ 12.5 
(P < 0.01) and by 24% to 102.5 ___ 10.0 (P < 0.01) nmol/25 mg per h at 0.1, 1 and 10 /xM GR79236, respectively. Rates of lactate 
release followed a similar but non-significant trend. Addition of GR79236 in the presence of ADA had no effect on rates of glycogen 
synthesis. Insulin stimulated rates of pyruvate or lactate release or of glycogen synthesis were unaffected by the addition of adenosine 
deaminase or GR79236 in human rectus abdominus muscle strips. Adenosine agonists may act indirectly to modulate insulin sensitivity of 
carbohydrate metabolism. 
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1. Introduction 
Adenosine has been shown to be a potent antilipolytic 
agent both in rat [1,2] and human [3] adipose tissue. 
Adipose tissue lipolysis is an important rate limiting step 
in the control of plasma free fatty acids levels. An increase 
in free fatty acids supply decreases insulin-mediated glu- 
cose metabolism [4] whereas decreased lipolysis increases 
insulin-mediated glucose disposal [5]. Skeletal muscle con- 
tains significant quantities of endogenous triglycerides lo- 
cated intracellularly [6-8]. Modulation of lipolysis within 
intramuscular triglyceride stores offers the potential of 
enhancing lucose metabolism via the glucose fatty acid 
cycle. This could be of practical benefit in NIDDM which 
is characterised by hyperglycaemia and high circulating 
free fatty acid levels. The receptors mediating the in- 
hibitory effect of adenosine on lipolysis have been de- 
scribed as being of the A1 receptor subtype [9,10]. The 
antilipolytic effect of A1 adenosine receptor agonists in the 
presence of ADA has been reported [9]. In skeletal muscle, 
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the actions of adenosine agonists such as 2-chloroadeno- 
sine and N6-2-phenylisopropyl adenosine and antagonists 
such as 8-phenyltheophylline on insulin-stimulated path- 
ways such as glycogen synthesis and glycolysis remain 
more controversial [11-13]. The present studies were de- 
signed to elucidate the dose-response effects of the new 
highly selective A1 adenosine agonist GR79236 upon in- 
sulin sensitivity in isolated rat soleus and human rectus 
abdominus muscle strips. 
2. Materials and methods 
2.1. Materials 
D-[U-14C]Glucose (287 mCi/mmol) was obtained from 
Amersham International Plc., UK. Bovine serum albumin 
(BSA), glycogen from bovine liver type IX and 2-chloro- 
adenosine were obtained from Sigma Chemical Co., UK. 
Lactate dehydrogenase, NAD, NADH and adenosine 
deaminase (ADA) were obtained from Boehringer 
Mannheim, Germany. Prior to use ADA was dialysed 
against 30 mM potassium phosphate buffer pH 7.0 at 4°C, 
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since the ammonium sulfate present in commercial prepa- 
rations of ADA was shown to decrease markedly rates of 
glycogen synthesis measured in rat soleus muscle strips 
following incubation (Table 1). The dialysate was diluted 
to a concentration of 100 U/ml  in phosphate buffer and 
stored in aliquots at -20°C. Dialysis and subsequent 
storage of ADA at - 20°C did not compromise the activity 
of the enzyme (Table 2). Scintillation fluid (opt±phase 
Hi-safe 2) from Wallac, UK. Crystalline monocomponent 
porcine insulin was a gift from Novo. GR79236 (N-(ls- 
trans-2-hydroxycyclopentyl)adenosine) was provided by 
Glaxo Group Research, UK. 
2.2. Tissue isolation 
2.2.1. Rat soleus muscle strips 
Male Wistar rats (150-200 g) were bred and maintained 
in house. They were fed ad lib on rat and mouse number 3 
breeding diet, produced by Special Diet Services, UK and 
allowed free access to water. Rats were fasted overnight 
(18 h) and then killed by cervical dislocation. Soleus 
muscle strips were isolated according to the method of 
Crettaz et al. [14]. The soleus muscle was exposed and 
separated into two strips each weighing between 20 and 40 
mg. The strips were tied at the tendons with cotton thread 
and mounted on stainless teel clips under uniform tension. 
2.2.2. Human rectus abdominus muscle strips 
Rectus abdominus muscle strips were prepared by the 
method of Argyraki et al., 1989 [15]. Biopsies of rectus 
abdominus were obtained from 11 consenting patients 
undergoing elective surgery for gastroenterological rea- 
sons. As a group, they were of normal weight (body mass 
index 24.3 + 1.29, mean _ SEM) and of mean age 60.1 + 
4.4 years (mean_ SEM; range 34.0 to 79.0 yr) with a 
fasting blood glucose level of 5.2 + 0.6 (mean_ SEM). 
None of the subjects had any known metabolic disorder or 
had taken any medication known to alter carbohydrate 
metabolism. The muscle was clamped before excision 
using double nosed stainless teel forceps so that resting 
fibre length was maintained. Strips weighing 20-40 mg 
were separated from the clamped tissue along the fibre line 
and mounted on special Plexiglass clips one at a time 
without loss of tension. 
2.3. Incubation 
Each strip was preincubated for 30 min at 37°C in a 
shaking water bath, in 3 ml of oxygenated Krebs Ringer 
bicarbonate buffer containing 1% (w/v)  defatted bovine 
serum albumin, 5.5 mM glucose, 5 mM pyruvate, 4 mM 
succinate and 5 mM glutamate. Strips were gassed contin- 
uously with 95% 02/5% CO 2. At the end of the preincu- 
bat±on, strips were transferred to 3 ml of fresh medium and 
incubated for a further 60 min at 37°C in a shaking water 
bath and were gassed for the first 15 min with 95% 
02/5% CO 2. ADA (1 U/ml), adenosine agonist and 
insulin (5 nM to produce sub-maximal stimulation) were 
present during both the preincubation and incubation when 
required. 
2.4. Estimation of the rate of glycogen synthesis 
Rates of glycogen synthesis were estimated by measur- 
ing the radioactivity incorporated into glycogen from D-[U- 
~4C]glucose, present in the final incubation. After incuba- 
tion, strips were rapidly cut off the clips, blotted dry, 
weighed and digested in 1 M NaOH for 15 min at 70°C. 
After deproteinisation f the sample with 20% trichloro- 
acetic acid (TCA), glycogen was precipitated by the stan- 
dard ethanol method [16] and radioactivity counted in a 
Beckman /3-scintillation counter. Glycogen formed was 
expressed as nmol of glucose incorporated per 25 mg of 
muscle per h. 
2.5. Estimation of lactate and pyruvate release 
Release of lactate and pyruvate into the incubation 
medium as an index of glycolysis, were determined spec- 
trophotometrically b  end point analysis in the perchloric 
extract of the incubation medium using a Cobas centrifugal 
analyser. Results were expressed as nmol of 
lactate/pyruvate formed per 25 mg of muscle per h. 
Table 1 
Comparison of a range of concentrations of adenosine deaminase and ammonium sulfate by measuring insulin-stimulated (50 nM) rates of D-[U-14 C]glu- 
cose incorporation i to glycogen, lactate release and pyruvate release in isolated rat soleus muscle strips where 5 mM ammonium sulfate is approx, the 
concentration f ammonium sulfate in 3 U/ml  ADA and 20 mM ammonium sulfate is approx, the concentration f ammonium sulfate in 12 U/ml  
Concn. (nmol/25 mg per h) ADA (U/m1) Ammonium sulfate (mM) 
0 3 12 5 20 
glycogen synthesis 161.1 ± 14.0 (6) 109.1 ±_ 8.1 (6) * * 68.9 ± 6.3 (6) * ~ * 107.3 ± 3.0 (2) 80.3 ± 9.6 (4) * * 
lactate release 452.5 ± 47.5 (5) 385.0 ± 20.0 (5) 405.0 ± 37.5 (5) 455.0 + 112.5 (2) 445.0 + 27.5 (4) 
pyruvate release 122.5 ± 10.0 (5) 122.5 ± 18.2 (5) 7.5 + 11.5 (5) 109.2 + 1.8 (2) 91.0 ± 11.8 (4) 
Results are expressed as mean + SEM where (n) refers to the number of separate incubations undertaken. Significant differences compared to insulin alone 
are denoted by: * * P < 0.01, * * * P < 0.001. 
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Table 2 
The rate of hydrolysis of adenosine as a measure of the activity of 0.05 U 
adenosine deaminase, prior to and post dialysis and after storage at 
-20°C for 3 mth 
Rate of hydrolysis of adenosine by 
adenosine deaminase (ADA) 
(/xmol/min) 
ADA in 3.2 M (NH4)2SO 4 0.054 
Freshly dialysed ADA 0.051 
ADA, dialysed and stored at 0.053 
- 20°C for 3 months 
lb). The addition of GR79236 in concentrations of 0.01, 
0.1 and 10 /xM in the presence of ADA had no effect on 
insulin-stimulated rates of glycogen synthesis (Fig. lc). 
In the isolated human rectus abdominus muscle strip 
preparation removal of endogenous adenosine by ADA 
had no effect on rates of pyruvate or lactate release or on 
rates of glycogen synthesis. There was also no significant 
effect of the adenosine agonist GR79236 in the presence of 
ADA on basal  or insulin-stimulated rates of pyruvate 
release, lactate release or glycogen synthesis (Table 4). 
2.6. Stat ist ical  analysis 
Results are expressed as mean + SEM. Statistical sig- 
nificance was assessed using paired or unpaired Student's 
t-test as appropriate. 
3. Results 
The action of a range of concentrations of the adenosine 
receptor agonist 2-chloroadenosine on insulin-stimulated 
rates of glucose metabolism in rat soleus muscle strips was 
examined. Removal of endogenous adenosine by addition 
of adenosine deaminase (ADA) to the incubation media 
had no effect on rates of pyruvate release (127 + 37.5 vs. 
140 __+ 45.0 nmol /25  mg per h in the presence of ADA), 
lactate release (532.5 + 34.0 vs. 502.5 + 32.5 nmol /25  
mg per h in the presence of ADA) or rates of glycogen 
synthesis (129.6 + 10.6 vs. 127.6 + 10.2 nmol /25  mg per 
h in the presence of ADA). The addition of 0.005, 0.05, 
0.5 and 5 /zM 2-chloroadenosine in the presence of ADA 
had no significant effect on rates of pyruvate release, 
lactate release or rates of glycogen synthesis (Table 3). 
Addition of GR79236, in the presence of ADA, in- 
creased rates of pyruvate release by 24% from 82.5 __+ 10.0 
to 102.5 ___ 10.0 nmol /25  mg per h (P  < 0.01), 27% to 
105.0 + 12.5 nmol /25  mg per h (P  < 0.01) and by 24% to 
102.5 + 10.0 nmol /25  mg per h (P  < 0.01) at 0.1, 1 and 
10 /xM GR79236 (Fig. la). Although rates of lactate 
release appeared to follow a similar trend there were no 
statistically significant differences in rates of lactate re- 
lease with either the addition of ADA alone or in the 
presence of increasing concentrations of GR79236 (Fig. 
4. Discussion 
We initially examined the effect of endogenous adeno- 
sine on carbohydrate metabolism in skeletal muscle by 
comparing metabolism under normal conditions in the 
presence or in the absence of endogenous adenosine. An 
excess of the enzyme ADA (1 U /ml ,  a concentration also 
used by Challis et al. [10] and Leighton et al. [17]) was 
used to convert adenosine to the inactive metabolite ino- 
sine. However, removal of endogenous adenosine had no 
effect on insulin-stimulated rates of pyruvate or lactate 
release or on rates of glycogen synthesis in rat soleus 
muscle strips or human rectus abdominus muscle strips. 
Addition of the adenosine agonist 2-chloroadenosine in the 
presence of ADA similarly had no effect on rates of 
insulin-stimulated pyruvate or lactate release or on rates of 
glycogen synthesis in rat soleus strips. However addition 
of the adenosine agonist GR79236 at concentrations of 0.1, 
1 and 10 /~M significantly increased rates of pyruvate 
release in rat soleus muscle strips although not in human 
rectus abdominus muscle strips. The increase in pyruvate 
release from soleus muscle strips after incubation in the 
presence of GR79236 may be an indirect effect of the 
ability of the adenosine agonist to inhibit lipolysis, since 
adenosine agonists do not appear to exert their effects 
upon the insulin action pathway directly [3]. GR79236 is a 
highly selective A1 adenosine receptor agonist [18] and is 
known to inhibit noradrenaline stimulated lipolysis in hu- 
man adipocytes to a greater extent than insulin [3]. 
GR79236 acts on A1 adenosine receptors and produces a 
greater antilipolytic response in adipose tissue dose for 
dose compared with other analogues [3] and hence appears 
to be a more potent agonist han 2-chloroadenosine. Skele- 
Table 3 
The effect of a range of concentrations of 2-chloroadenosine o  insulin-stimulated (5 nM) rates of o-[U-14C]glucose incorporation i to glycogen, lactate 
release and pyruvate release in the presence of adenosine deaminase (1 U/ml) in isolated rat soleus muscle strips 
Concn. (nmol/25 mg per h) Insulin (5 nM) ADA (1 U/ml) 2-Chloroadenosine (/zM) 
0.005 0.05 0.5 5 
glycogen synthesis 129.6 _+ 10.6 127.6 + 10.2 116.1 + 11.6 118.7 + 12.4 121.1 + 12.8 107.8 + 15.1 
lactate release 532.5 + 35.0 502.5 + 32.5 477.5 _+ 37.5 522.5 ___ 32.5 560.0 _ 50.0 515.0 + 97.5 
pyruvate r lease 127.5 + 37.5 140.0 + 45.0 125.0 + 30.0 145.0 + 27.5 157.5 + 32.5 152.5 ___ 35.0 
The results are expressed as means + SEM from 5 separate incubations 
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Fig. 1. The effect of a range of concentrations of GR79236 (shaded 
boxes) on sub-maximally insulin-stimulated (5 nM) rates of (a) pyruvate 
release, (b) lactate release and (c) ~[U-14C]glucose incorporation i to 
glycogen i  the presence of adenosine deaminase (1 U/ml) in isolated rat 
soleus muscle strips. The results are expressed as means ±sem from 13 
separate incubations. Significant differences compared to in the presence 
of insulin and adenosine deaminase are denoted by: * * P < 0.01. 
tal muscle contains significant quantities of endogenous 
triglyceride [6,8], and a decrease in lipolysis of intra- 
cellular triglyceride by GR79236 may be expected to 
decrease the rate of fatty acid oxidation and reciprocally 
increase the rate of glycolysis and glucose oxidation. 
Randle et al. [19], hypothesised that an increase in lipid 
availability in rat heart and diaphragm in vitro resulted in a 
decrease in glucose uptake and utilisation by the glucose 
fatty acid cycle. In adipose tissue, the existence of a 
tr iglyceride/fatty acid cycle ensures that triglycerides are 
constantly being mobilised and reesterified [20] and an 
increase in flux in skeletal muscle could provide a rapidly 
mobilised energy source for muscle. Lipolysis and subse- 
quent oxidation of endogenous fatty acids within skeletal 
muscle may occur at a sufficient rate to inhibit glucose 
utilisation. 
The present data contrast with those of Leighton et al. 
[17] and Espinal et al. [11] who found that addition of 
ADA stimulated lactate release in the presence of a sub- 
maximal concentration of insulin (0.85 nM). This they 
suggested to be receptor mediated since the adenosine 
receptor antagonist 8-phenyltheophylline exerted a similar 
effect to ADA [12] whereas the adenosine receptor ago- 
nists 2-chloroadenosine or N6-phenpropyladenosine de- 
creased the sensitivity of this process to insulin [10,11]. 
Basal and maximally stimulated rates of lactate release 
were unaffected by ADA, antagonists or agonists of adeno- 
sine. The addition of N6-phenylisopropyladenosine and/or  
ADA to isolated stripped soleus muscle strips appeared to 
have no effect on basal or insulin-stimulated rates of 
glycogen synthesis [11]. This they interpreted to mean that 
adenosine exerted its action directly at a post insulin 
receptor level, namely glucose transport [10]. There is no 
convincing evidence however, for adenosine to exert a 
direct effect on the insulin signalling pathway itself. Rather 
the evidence points to a powerful antilipolytic action both 
in adipose tissue and skeletal muscle. 
The concentration of insulin used in the present study 
was submaximal, and chosen because it represented the 
mean EDs0 for rates of glycogen synthesis in rat soleus 
muscle strips (7 nM) and human rectus abdominus muscle 
strips (4 nM). As anticipated, insulin-stimulated rates of 
glycogen synthesis in the rat soleus muscle strips were 15 
times greater than in the human rectus abdominus muscle 
strips. Rates of lactate and pyruvate release were 24% and 
33% greater espectively in human rectus abdominus mus- 
cle strips compared to rat soleus muscle strips. Differences 
Table 4 
The effect of GR79236 (1 /xM) in the presence of adenosine deaminase (1 U/ml) on basal and submaximally insulin-stimulated rates of pyruvate r lease, 
lactate release and o-[U-14 C]glucose incorporation i to glycogen in isolated human rectus abdominus muscle strips 
Conch. (nmol/25 mg per h) Basal Insulin + ADA GR79236 5 nM Insulin + ADA GR79236 
pyruvate r lease 62.5 ± 12.5 (1 l) 57.5 ± 12.5 (3) 67.5 + 10.0 (3) 70.0 ± 15.0 (5) 87.5 ± 17.5 (5) 87.5 + 22.5 (5) 
lactate release 455.0 4- 45.0 (11) 505.0 ± 95.0 (5) 520.0 +_ 65.0 (3) 462.5 ± 50.0 (7) 515.0 ± 47.5 (7) 465.0 ± 52.5 (7) 
glycogen synthesis 5.6 4- 0.5 (7) 5.6 ± 0.8 (7) 5.8 4- 0.7 (7) 7.0 ± 1.1 (4) 7.4 ± 0.7 (8) 7.0 ± 0.8 (7) 
The results are expressed as means ± SEM where (n) refers to the number of separate incubations undertaken. 
J.M. Webster et al. / Biochimica et Biophysica Acta 1316 (1996) 109-113 113 
in fuel utilisation and glucose disposal in the rat soleus 
muscle strips compared to the human rectus abdominus 
muscle strips may reflect differences in fibre type compo- 
sition of the individual muscles concerned. Rat soleus 
muscle is composed predominantly of type I fibres and is 
an oxidative muscle with a high respiratory capacity [21]. 
Human rectus abdominus muscle has equal amounts of 
type I and II fibres [22] and hence has the capacity for 
aerobic metabolism as well as a high glycolytic apacity. 
Metabolic variation between different species has been 
highlighted in many studies [23,24] and it would not be 
surprising to find a difference in insulin sensitivity or 
responsiveness between two muscle types since hetero- 
geneity of insulin action has already been demonstrated in 
individual rat muscles in vivo [25]. However, this study 
demonstrates no effect of the powerful adenosine agonist 
GR79236 on the insulin sensitivity of glycogen metabolism 
in either tissue. 
The physiological actions of adenosine have been an 
active subject of research for almost three decades. Most 
cells are able to release adenosine [26] and effects of 
adenosine are mediated via specific receptors. Receptors 
mediating the inhibitory effect of adenosine on lipolysis 
have been described as the A1 receptor subtype [9,10]. 
That adenosine may play a physiological role in skeletal 
muscle remains more controversial. It has been proposed 
by studying the effect of selective A1 and A2 adenosine 
agonists on glucose utilisation, that adenosine mediates its 
actions in rat skeletal muscle via the A1 adenosine recep- 
tor [10]. However, Northern blot analysis was unable to 
detect A1 receptor mRNA in rat skeletal muscle [27] or in 
human skeletal muscle (unpublished ata, Harris CA and 
Pun KT, Receptor Pharmacology Unit, Glaxo Wellcome) 
although A1 mRNA was found to be present in other 
human tissues including adipose tissue, brain, heart and 
kidney. Our biological action data suggests that adenosine 
action upon muscle by A1 selective adenosine receptor 
agonists is minimal, and that high affinity AI adenosine 
receptors may not exist in human or rat muscle per se. 
Further work is therfore required to clarify the status of 
adenosine receptors in skeletal muscle. 
In summary, the present data suggests that adenosine 
does not have a major role as a modulator of the actions of 
insulin on glycogen synthesis in skeletal muscle. However, 
as a potent antilipolytic agent adenosine may act indirectly 
via the glucose fatty acid cycle to increase glycolytic flux. 
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